Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus
- 319 Downloads
There is a paucity of data on the impact of chronic rheumatic diseases on functional disability and overall health-related quality of life (HRQOL) in Africans. Materials and methods: We compared Black South Africans (BSA) with rheumatoid arthritis (RA) (n=50) and systemic lupus erythematosus (SLE) (n=50) to geographically and ethnically matched controls cared for at a tertiary care facility. The modified health assessment questionnaire (mHAQ) and Medical Outcome Study short-form 36 (SF-36) scores and indices of disease activity and organ damage were collected from each group. Results: Compared to the controls, both the RA and SLE groups fared significantly worse in respect of all the domains and summary scales of the SF-36. Compared to the SLE group, the RA group scored significantly worse with respect to the mHAQ disability index (mHAQ-DI), physical function and bodily pain (BP) SF-36 subscales, and SF-36 summary physical component score (SF-PCS). In the RA group, both the mHAQ-DI and SF-PCS correlated strongly (p<0.005) with the tender joint count, patient global assessment, 28-joint composite disease activity score, physician global assessment, and pain score. The SF-PCS showed only a weak inverse correlation with the swollen joint count (r=−0.29, p<0.05). In the SLE group, the systemic lupus erythematosus disease activity index correlated inversely best with the SF-36 general health subscale (r=−0.56, p<0.0001) and, to a lesser extent, with the mental health, BP, and vitality subscales, and SF-PCS and SF-mental component summary scores. Conclusion: Both RA and SLE have profound effects on HRQOL in BSA, with BP and physical disability particularly worse in RA patients. Disease activity, rather than organ damage or sociodemographic characteristics, correlates best with certain aspects of functional disability and HRQOL in both RA and SLE. Further longitudinal studies are needed to assess the clinical utility of measures of functional disability and HRQOL in this population.
KeywordsAfrica Functional disability Quality of life Rheumatoid arthritis Systemic lupus erythematosus
RB was funded by the Medical Endowment Fund, University of the Witwatersrand. We would like to thank Dr. Matthew Liang for his expert advice.
- 6.McEntergart A, Morrison E, Capell HA, Duncan MR, Porter D, Madhok R et al (1997) The effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis 56:410–413Google Scholar
- 8.Alarcon GS, McGwin G, Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ et al (2004) Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 51:465–474PubMedCrossRefGoogle Scholar
- 15.Smolen JS, Breedveld FC, Eberl G et al (1995) Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 32:531–537Google Scholar
- 16.Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related condition by standard reference films. Acta Radiol Diagn 18:481–491Google Scholar
- 18.Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369PubMedCrossRefGoogle Scholar
- 19.STATISTICA for Windows (5.1 edn) (1998) Statsoft, TulsaGoogle Scholar
- 20.Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW et al (2005) Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol 32:590–601PubMedGoogle Scholar
- 25.Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA et al (1997) Consistency and validity of patient administered assessment of quality of life by the MOS SF-36: its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 24:1608–1614PubMedGoogle Scholar